1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: 3T ADC values in malignant neck lesions
Age, y/Sex Lesion Stage ADC, × 10⁻³ mm²/s
65/M Sinonasal undifferentiated SCC (P) T4N0M0 0.719 ± 0.157
35/M Sinonasal undifferentiated SCC (P) T4N0M0 1.042 ± 0.068
51/F SCC Parotid (P) T4N2M1 1.064 ± 0.162
61/M SCC palatine tonsil (P) T4N2BM0 0.847 ± 0.083
62/M SCC palatine tonsil (P) T4N3M1 0.733 + 0.055
62/M SCC palatine tonsil (MD) T3N1M0 1.261 ± 0.168
59/M SCC base of tongue (P) T2N3M0 0.955 ± 0.095
65/F SCC soft palate (P) T1N3M0 1.033 ± 0.183
78/F SCC nasopharynx (W) T4N0M0 1.319 ± 0.194
58/M SCC supraglottis (MD) T4N2BM0 1.278 + 0.070
83/M SCC supraglottis (MD) T4N0M0 1.138 ± 0.148
43/M SCC oropharynx (MD) T4N1M0 1.359 + 0.087
90/F SCC orbit (W) T4N1M1 1.055 ± 0.047
40/F Adenosquamous cell carcinoma skull base T4N0M0 1.649 ± 0.229
57/F Carcinoma ex pleomorphic adenoma (parotid) T2N1M0 1.241 ± 0.194
69/M Orbital B-cell lymphoma 3A 0.438 ± 0.099
Note:—SCC indicates squamous cell carcinoma; W, well-differentiated; MD, moderately differentiated; P, poorly differentiated; F, female; M, male; ADC, apparent diffusion coefficient.